Global pre-packed chromatography columns market is anticipated to exhibit lucrative growth over the forecast period owing to the rising R&D in the analytical departments of pharmaceutical and biotechnology sector. A number of factors such as new international global alliances between leading research institutes, food & drug development firms, and beverage analysis are expected to drive the market. Some other market drivers include rapid increase in the demand for biopharmaceutical products such as vaccines and monoclonal antibodies, GMP and GDP certifications for new pharmaceutical excipients, growth of drug discovery applications, and increase expenditure for the novel molecules in the nutraceuticals. Upcoming need of the products with international quality standards is expected to further drive this market. Moreover, associated benefits with such columns are reduction in the labor amount, time, maintenance, and operational flexibility provided for different users coupled with high productivity per run are factors expected to impact the pre-packed chromatography columns market growth positively.
Pre-packed chromatography columns market is segmented on the basis of types and applications. Based on types, the market is classified as 1-100 ml, 100-1000 ml, and more than 1L depending on the filling capacity of column. Pre-packed columns with more than 1L filling capacity accounted for the largest market share with respect to revenue in 2014 and are expected to continue to maintain the dominant market position in the coming seven years. Factors that attributed towards this large share include reduction in cost of resins and the viability of larger-sized pre packed column for analysis of different chemical compounds. Large sized columns are more preferred owing to efficient separation of the molecules in a compound thus providing exact estimation of the impurities and heavy metals as a result of the large column surface area. Moreover, rising advancements in the segment that are anticipated to provide technical, logistic and economical advantages for analysis are expected to fuel the segment growth over the forecast period. On the basis of applications, pre-packed chromatography column market is segregated into nutraceuticals, academics, food & beverages, pharmaceuticals, environmental biotechnology, cosmetics, and research institutes, and analytical laboratories. Pharmaceutical industries held the largest share in revenue in 2014 owing to development of novel drug molecules and analysis of the active pharmaceutical ingredients (API) as well as the finished products in order to determine the biological potency of the drug products. This segment is expected to exhibit significant growth throughout the forecast period as a consequence of increasing R&D for novel drug formulations and their analysis to determine the content and purity of drug components.
Geographically, this Pre-packed chromatography columns market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America held the largest share amongst all regions of market in 2014 owing to the presence of numerous dominant players for the pharmaceutical and biotechnology segments in the region and availability of a technologically advanced R&D infrastructure. Furthermore, US FDA approval for the high performance layer chromatographic analytical instruments also contributed towards the large share of the regional market. Asia Pacific region is expected to grow at a considerable rate over the forecast period due to the presence of upcoming developments in monoclonal antibodies which constitute largest biologics product category under clinical development phase. These products are analyzed using chromatographic techniques for analysis using various principles such as ion exchange, affinity, and hydrophobic interaction. The other factors for the market growth include WHO GMP implied regulations for quality in the food and drug industries. The rapid growth of process chromatography technologies in agriculture and pharmaceutical industries is expected to drive the growth of pre-packed columns market.
Global spectrophotometers market has Agilent Technologies, GE Healthcare Lifesciences, Atoll GmbH, EMD Millipore, Repligen Corp., Thermo Fisher Scientific Inc., and Phenomenex Inc. as the leading players. There is a high competitive rivalry amongst these companies and is expected to remain unchanged over the forecast period. The upcoming market strategies of players include advancements such as introduction of disposable and single-use columns. The other advancements are incorporation of different combinations of ion-exchange & affinity resins for analysis of versatile range of biomolecules and chemicals. Competitive strategies of the market players include collaborations with the analytical laboratories and research institutes in order to maintain their market share and position.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.